Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v32-FR Version v17-EN
Language French English
Date Updated 2020-10-28 2020-07-02
Drug Identification Number 02283174 02283174
Brand name ALTACE HCT ALTACE HCT
Common or Proper name ALTACE HCT ALTACE HCT
Company Name BAUSCH HEALTH, CANADA INC. BAUSCH HEALTH, CANADA INC.
Ingredients HYDROCHLOROTHIAZIDE RAMIPRIL HYDROCHLOROTHIAZIDE RAMIPRIL
Strength(s) 25.0MG 5.0MG 25.0MG 5.0MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 28 tabs 28 tabs
ATC code C09BA C09BA
ATC description ACE INHIBITORS, COMBINATIONS ACE INHIBITORS, COMBINATIONS
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date
Actual start date 2020-01-24 2020-01-24
Estimated end date 2020-07-10
Actual end date 2020-09-29
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments artwork related artwork related
Health Canada comments